Heterogeneous NLRP3 inflammasome signature in circulating myeloid cells as a biomarker of COVID-19 severity

Dysregulated immune response is the key factor leading to unfavorable coronavirus disease 2019 (COVID-19) outcome. Depending on the pathogen-associated molecular pattern, the NLRP3 inflammasome can play a crucial role during innate immunity activation. To date, studies describing the NLRP3 response...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood Adv
Auteurs principaux: Courjon, Johan, Dufies, Océane, Robert, Alexandre, Bailly, Laurent, Torre, Cédric, Chirio, David, Contenti, Julie, Vitale, Sébastien, Loubatier, Céline, Doye, Anne, Pomares-Estran, Christelle, Gonfrier, Géraldine, Lotte, Romain, Munro, Patrick, Visvikis, Orane, Dellamonica, Jean, Giordanengo, Valérie, Carles, Michel, Yvan-Charvet, Laurent, Ivanov, Stoyan, Auberger, Patrick, Jacquel, Arnaud, Boyer, Laurent
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2021
Sujets:
Clinical Trials and Observations
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7942161/
https://ncbi.nlm.nih.gov/pubmed/33683342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003918
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires